This bill mandates the Commissioner of Health to create a program within the Department of Health aimed at purchasing and distributing xylazine test strips to entities that provide authorized harm reduction services in New Jersey. The program will involve overseeing bulk purchasing and distribution of these test strips upon request from the entities, as well as establishing an internet website to inform the public about xylazine test strips and their availability through these services.

Additionally, the bill allows the Commissioner of Health to adopt necessary rules and regulations to implement its provisions and appropriates funds from the General Fund to support the program. The initiative is intended to be funded by available federal resources and any state funds allocated for this purpose, with the act taking effect immediately upon passage.